August 1, 2025 · Form 4 insider transaction
ZACCARDELLI DAVID sold 208,912 shares of Verona Pharma Plc at $13.14 per share, a transaction worth $2.75M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.; The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 instruction entered into on May 24, 2022 solely with the intent to cover taxes in connection with the vesting of Restricted Share Units ("RSUs").; The price reported represents the sale price of the ADSs divided by eight (8).; Consists of (i) 2,375,000 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 296,875 ADSs); and (ii) 11,001,144 Ordinary Shares underlying 1,375,143 ADSs.